InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the detailed record of transactions filed by Foresite Capital Management V, LLC. Director active across 4 companies, notably Pardes Biosciences, INC.. In total, 13 reports have been published. Breakdown: 5 buys · 0 sell. Total volume traded: €6.3m. Activity tracked since 1 December 2022. The latest transaction was filed on 10 August 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Foresite Capital Management V, LLC is a declarant linked to Latigo Biotherapeutics, Inc., Theseus Pharmaceuticals, Inc., Pardes Biosciences, INC. and ALUMIS INC. It has filed 13 filings in total, and across the 13 sampled filings, buys amount to EUR 6324436 between 2022-12-05 and 2026-08-10, with a transaction nature of C.